Short answer
Prestige Consumer Healthcare Inc. (PBH) filed an 8-K current report with the SEC on July 9, 2026 reporting Item EX-99.1 (Exhibit EX-99.1). OTC Wellness Business generated net sales of $51.7M and net income of $12.6M in Q1 2026.
Prestige Consumer Healthcare Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item EX-99.1 · Exhibit EX-99.1
- OTC Wellness Business generated net sales of $51.7M and net income of $12.6M in Q1 2026
- Net income declined from $14.8M, while advertising and promotions increased to $12.6M from $10.2M
- PCH agreed on March 19, 2026 to acquire brands including Breathe Right, Dimetapp, Primatene, and Dristan
- Business produced $17.3M operating cash flow, entirely transferred to parent, with no reported cash balance
- Carve-out results include allocated corporate costs and may not represent standalone profitability after acquisition
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Prestige Consumer Healthcare Inc. 8-K filings
Get the next PBH 8-K as it lands
Follow PBH for push alerts, or ask the research agent what this filing means.